...
首页> 外文期刊>Eurosurveillance >Emergence of carbapenemase-producing Enterobacteriaceae in France, 2004 to 2011
【24h】

Emergence of carbapenemase-producing Enterobacteriaceae in France, 2004 to 2011

机译:2004年至2011年法国生产碳青霉烯酶的肠杆菌科的出现

获取原文

摘要

Emergence of carbapenemase-producing Enterobacteriaceae (CPE) is currently a major public health concern worldwide. This study showed that 53 episodes of CPE infection or colonisation have been notified by French healthcare facilities since 2004. A sharp increase in the number of notifications was observed in the last three years. Oxacillinase (OXA)-48 and Klebsiella pneumoniae carbapenemase (KPC) beta-lactamases were the most frequent enzymes reported in these episodes. The index cases in most episodes were patients with a history of hospitalisation abroad within the previous year. Around a third of the episodes (n=18) led to secondary transmission in hospitals but most of them were controlled due to reinforced measures. Reinforcement of screening and control measures at national level when there is cross-border transfer of patients, along with overall reinforcement of infection control and antimicrobial stewardship worldwide, is urgently needed to contain the spread of CPE.
机译:目前,产生碳青霉烯酶的肠杆菌科(CPE)的出现是全球主要的公共卫生问题。这项研究表明,自2004年以来,法国医疗机构已通报53例CPE感染或定植。在最近三年中,通报数量急剧增加。在这些事件中,最常见的酶是奥沙西林酶(OXA)-48和肺炎克雷伯菌肺炎克雷伯菌(KPC)β-内酰胺酶。大多数事件中的索引病例是前一年在国外住院的患者。大约三分之一的发作(n = 18)导致了医院的继发性传播,但由于采取了加强措施,因此大多数病例得到了控制。迫切需要在国家范围内加强跨境转移患者时的筛查和控制措施,以及在全球范围内全面加强感染控制和抗菌素管理,以遏制CPE的传播。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号